Top compounds associated with response to RGS12


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 8e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.14 1e-05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.15 5e-05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA TW 37 GDSC1000 pan-cancer AAC -0.14 6e-05
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.14 6e-05
Download CSV